Macroprolactin does not cause any problems in the body, but it is important to exclude as a cause of high prolactin, as patients with macroprolactin do not need any further investigation or treatment
Following manufacturer's instructions we treated cells with pure medium (TCS CellWorks, Buckingham, United Kingdom), or with VEGF as positive control (2 ng/ml), Suramin as negative control (20 uM) and BPC 157 in two different final concentrations (10 ug/ml and 2 ug/ml)
Results are highly individualized but are focused on sustainable progress that reduces health risks over time
According to the clinical expert consulted for this review, the HRQoL outcomes or formal HRQoL outcomes in general are not typically used in clinical practice as far as routine management of patients with diabetes goes
This represents a big step forward, as drug manufacturers have shied away from investing in research for adjunctive therapies in the past
We understand that your health journey is unique, which is why our platform is a user-friendly and supportive space where individuals receive personalized, medically supervised care, designed to make sustainable weight loss attainable and tailored to the individual